Neuropeptides
Semax
Lyophilized Semax, unreconstituted. It is a synthetic peptide discussed in experimental neuropeptide and attention research.
5 mg
€22.99
- Amount
- 5 mg, 10 mg
- CAS
- 80714-61-0
- Storage
- −20 °C · dry · dark
- COA
- Supplier certificate pending
About this material
Semax is supplied by Rierink Compounds as a laboratory research material. Made in Europe. It is a synthetic peptide discussed in experimental neuropeptide and attention research. It sits with the peptides studied in laboratory research on neuropeptide signaling. The material is a lyophilized powder and is supplied unreconstituted. The companion reagent listed for it is BAC water. Store at −20 °C, dry and protected from light. For laboratory research use only. Not a medicine. Not for human or veterinary use. Rierink does not publish reconstitution volumes, dosing, or administration guidance.
Research context
Semax is a synthetic peptide discussed in research on neuropeptide signaling, including experimental work on attention and stress-related models. The literature is not a use instruction for this vial.
Published studies describe a research material and a study design. They are not a protocol for this vial, not a dose, and not a permission for human or veterinary use.
Recommended reagent
This is the laboratory reagent listed with this lyophilized material.
Certificates
These certificates come from our supplier and relate to the supplier's batches. They are not Rierink's own independent tests of the exact vial you receive. Every Rierink vial carries our own internal lot number, and independent testing of our own lots is underway; results will be published per lot. We welcome independent testing: any customer or lab is free to test our products, and we're happy to share results sent to us.
Supplier certificate pending
Research briefings
- Published Reports on DihexaIndexed cell and animal papers describe dihexa as a synthetic angiotensin IV analog studied for hepatocyte-growth-factor and synaptogenesis readouts, distinct from the ACTH-fragment, tuftsin-related, and tripeptide nootropic literature alre
- Semax in a 2025 spinal cord injury mouse paperA 2025 British Journal of Pharmacology report described Semax in female mice with spinal cord injury and in neuroinflammation models, with computational target predictions. Findings are study reports only.
- Semax in two 2025 animal-model papersTwo 2025 papers reported animal-model measurements after Semax exposure in transgenic Alzheimer mice and in female mice after spinal cord injury. Neither paper is a clinical study.
Trustpilot
A small laboratory is built one honest sentence at a time.
We're new on Trustpilot and don't have any reviews yet. Be one of the first to share your experience.
We are still the company that picks up the phone. The next researcher finds us because someone wrote down what actually happened: the lot that matched the label, the parcel that arrived late, the reply that took a day too long. That public record is how a young lab earns a name.
Write the first review